Holly Fullman, n/a
Medical Student
Rowan-Virtua School of Osteopathic Medicine
Chatham, New Jersey, United States
Pooja Patel, n/a
Medical Student
Rowan-Virtua School of Osteopathic Medicine
Edison, New Jersey, United States
Richard Jermyn, DO
Doctor of Osteopathy
Rowan-Virtua School of Osteopathic Medicine
Stratford, New Jersey, United States
The study was performed following PRISMA guidelines for scoping reviews. Three databases were used (MEDLINE, Web of Science, and PubMed). Peer-reviewed articles that assessed FTS accessibility, awareness, and knowledge within rural communities of the United States were included. Studies not within the US or the four states that ban FTS as of October 2024 (ND, TX, IN, IA) were excluded. Studies were not excluded by publication type or year.
Results: Seven studies met inclusion criteria, focusing on FTS and other harm reduction services. The evidence shows that FTS are not widely known or accessible within rural populations across the US due to the high stigma and lack of resources surrounding rural drug use. FTS interest increased after people who inject drugs (PWID) were exposed to its benefits. Importantly, PWID were less likely to consume a drug that tested positive for fentanyl.
Conclusions: Many PWID express fear over fentanyl’s growing presence within methamphetamine and opioids. Currently, PWID have resorted to riskier methods of detecting fentanyl, underscoring the need for FTS within rural communities. Increasing access to FTS can be easily achievable in rural areas and will increase the likelihood of its usage. One limitation is the lack of research exploring FTS, as they have recently become legalized. Further research of FTS will lead to decreased incidents of fentanyl-related overdose.